Create a free QxMD account to receive personalized paper recommendations, relevant to your practice.

Get Started

LETTER

Atypical Gianotti-Crosti syndrome following administration of the AS03-adjuvanted H1N1 vaccine

Joseph M Lam

Journal of the American Academy of Dermatology 2011, 65 (4): e127-e128

No abstract text is available yet for this article.

Full Text Links

Find Full Text Links for this Article

You are not logged in. Sign Up or Log In to join the discussion.

Gianotti-Crosti syndrome after H1N1-influenza vaccine. Annebeth Kroeskop, Amy B Lewis, Fe A F Barril, Keith E Baribault Pediatric Dermatology 2011, 28 (5): 595-6

Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months. Alfonso Carmona, Félix Omeñaca, Juan C Tejedor, Jose M Merino, Tejaswini Vaman, Ilse Dieussaert, Paul Gillard, Javier Arístegui Vaccine 2010 August 16, 28 (36): 5837-44

Immunogenicity and safety of a novel AS03(A)-adjuvanted H1N1 2009 pandemic influenza vaccine in adults in Japan. Hideyuki Ikematsu, Hideaki Nagai, Masahiro Kawashima, Yasunobu Kawakami, Kazuyoshi Tenjinbaru, Atsushi Maeda, Ping Li, Paul Gillard, François Roman Human Vaccines 2010, 6 (11): 888-93

Immunogenicity and safety of AS03-adjuvanted H1N1 pandemic vaccines in children and adolescents. J Garcia-Sicilia, P Gillard, A Carmona, J C Tejedor, J Aristegui, J M Merino, U Behre, A Caplanusi, T Vaman, I Dieussaert Vaccine 2011 June 10, 29 (26): 4353-61

AS03(A)-Adjuvanted influenza A (H1N1) 2009 vaccine for adults up to 85 years of age. François Roman, Tejaswini Vaman, Froukje Kafeja, Emmanuel Hanon, Pierre Van Damme Clinical Infectious Diseases 2010 September 15, 51 (6): 668-77

Gianotti-Crosti syndrome in association with Epstein-Barr virus altered by ampicillin. D C Hefelfinger Alabama Medicine: Journal of the Medical Association of the State of Alabama 1985, 55 (4): 16-8

Antibody response after a single dose of an AS03-adjuvanted split-virion influenza A (H1N1) vaccine in heart transplant recipients. Sven Meyer, Matti Adam, Brunhilde Schweiger, Corina Ilchmann, Christine Eulenburg, Edgar Sattinger, Hendrik Runte, Michael Schlüter, Tobias Deuse, Hermann Reichenspurner, Angelika Costard-Jäckle Transplantation 2011 May 15, 91 (9): 1031-5

Evaluation of adjuvanted pandemic H1N1(2009) influenza vaccine after one and two doses in young children. David W Scheifele, Brian J Ward, Marc Dionne, Otto Vanderkooi, Joanne M Langley, Simon Dobson, Yan Li, Barbara Law, Scott A Halperin et al. Pediatric Infectious Disease Journal 2011, 30 (5): 402-7

Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study. Isabel Leroux-Roels, François Roman, Sheron Forgus, Cathy Maes, Fien De Boever, Mamadou Dramé, Paul Gillard, Robbert van der Most, Marcelle Van Mechelen, Emmanuel Hanon, Geert Leroux-Roels Vaccine 2010 January 8, 28 (3): 849-57

Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study. Cem Gabay, Michael Bel, Christophe Combescure, Camillo Ribi, Sara Meier, Klara Posfay-Barbe, Stéphane Grillet, Jörg D Seebach, Laurent Kaiser, Werner Wunderli, Pierre-André Guerne, Claire-Anne Siegrist et al. Arthritis and Rheumatism 2011, 63 (6): 1486-96

Make the most of Read.
Download the mobile app.

Use Read by QxMD to access full text via your institution or open access sources.

Read also provides personalized recommendations to keep you up to date in your field.

Existing User

New to Read

Read